CI / Cigna (CI) to Add Three Biosimilars to NPF, Enable Cost Savings

The SPDR S&P 500 ETF posted its third consecutive losing month in October, the first time this has happened since I started tracking this series in Se more_horizontal

Cigna (CI) came out with quarterly earnings of $6.77 per share, beating the Zacks Consensus Estimate of $6.66 per share. This compares to earnings of more_horizontal

Cigna Group Inc. CI, +0.07% topped quarterly revenue expectations Thursday while logging increased counts of pharmacy and medical customers. The compa more_horizontal

Cigna Corp raised its full-year profit forecast on Thursday, banking on strength in its pharmacy benefit unit and lower-than-expected insurance claims more_horizontal

Blue-chip companies are very well established, have an excellent reputation and boast a history of providing investors with consistent returns. Blue- more_horizontal

Evaluate the expected performance of Cigna (CI) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line more_horizontal

Cigna's (CI) third-quarter results are likely to reflect growth in medical customers and pharmacy revenues. more_horizontal

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre more_horizontal